Free Trial

ClearPoint Neuro Q1 2023 Earnings Report

ClearPoint Neuro logo
$12.14 -0.95 (-7.26%)
As of 04/3/2025 04:00 PM Eastern

ClearPoint Neuro EPS Results

Actual EPS
-$0.23
Consensus EPS
-$0.18
Beat/Miss
Missed by -$0.05
One Year Ago EPS
N/A

ClearPoint Neuro Revenue Results

Actual Revenue
$5.43 million
Expected Revenue
$5.21 million
Beat/Miss
Beat by +$220.00 thousand
YoY Revenue Growth
N/A

ClearPoint Neuro Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Remove Ads

ClearPoint Neuro Earnings Headlines

ClearPoint Neuro (NASDAQ:CLPT) Price Target Raised to $25.00
This almost killed Elon Musk (chilling details emerge)
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
ClearPoint Neuro (CLPT) Receives a Buy from Stifel Nicolaus
ClearPoint Neuro reports Q4 revenue $7.8M, consensus $8.23M
See More ClearPoint Neuro Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ClearPoint Neuro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ClearPoint Neuro and other key companies, straight to your email.

About ClearPoint Neuro

ClearPoint Neuro (NASDAQ:CLPT) operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

View ClearPoint Neuro Profile

More Earnings Resources from MarketBeat